[40] Construction of MDR1 adeno-associated virus vectors for gene therapy
This chapter discusses the construction of multidrug resistance gene (MDR1) adeno-associated virus vectors (AAV) for gene therapy. Because of the large size of the MDR1 cDNA, the AAV coding sequences must be deleted prior to the insertion of MDR1 between the inverted terminal repeats (ITRs) of recom...
Gespeichert in:
| Veröffentlicht in: | Methods in Enzymology 1998, Vol.292, p.538-545 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 545 |
|---|---|
| container_issue | |
| container_start_page | 538 |
| container_title | Methods in Enzymology |
| container_volume | 292 |
| creator | Baudard, Marion |
| description | This chapter discusses the construction of multidrug resistance gene (MDR1) adeno-associated virus vectors (AAV) for gene therapy. Because of the large size of the MDR1 cDNA, the AAV coding sequences must be deleted prior to the insertion of MDR1 between the inverted terminal repeats (ITRs) of recombinant AAV (rAAV) vectors meant for transduction protocols. Whether all rep negative rAAV vectors are capable of stable integration, the mechanisms that contribute to site-specific integration needs to be investigated. The fact that rAAVs frequently remain episomal and may be diluted and lost with cell division may limit the use of AAV vectors when long-term expression is expected. Selectable markers, such as MDR1 may be possible to maintain nonintegrated episomal rAAV in proliferating cells because only cells carrying such episomal AAV-MDR1 survive the selection. |
| doi_str_mv | 10.1016/S0076-6879(98)92042-0 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_elsev</sourceid><recordid>TN_cdi_pubmed_primary_9711581</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0076687998920420</els_id><sourcerecordid>9711581</sourcerecordid><originalsourceid>FETCH-LOGICAL-e262t-1a821711205253321c04fdcde1f999248f2d57504ee2a348b693ae53db2dd6b93</originalsourceid><addsrcrecordid>eNo9kMlOwzAQhi0WlVL6CJV8hEPASxzbJ4TCVqkIieWEkOXEEzCicWWnlfr2pIuYyxz-0cw3H0ITSi4pocXVKyGyyAol9blWF5qRnGXkAA2pEDKTWqlDdEooo4pRzcURGv7Pn6BxSj-kr1yzXMoBGmhJqVB0iKYfOfnEZWhTF5d150OLQ4Ofbl8otg7akNmUQu1tBw6vfFwmvIK6CzHhJkT8BS3g7huiXazP0HFjfxOM932E3u_v3srHbPb8MC1vZhmwgnUZtT1gf50RwQTnjNYkb1ztgDZa93iqYU5IQXIAZnmuqkJzC4K7ijlXVJqP0GS3d7Gs5uDMIvq5jWuzf6nPr3c59BArD9Gk2kNbg_OxRzcueEOJ2Tg1W6dm48hoZbZODeF_9BJkgQ</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>[40] Construction of MDR1 adeno-associated virus vectors for gene therapy</title><source>MEDLINE</source><source>ScienceDirect eBooks</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Baudard, Marion</creator><creatorcontrib>Baudard, Marion</creatorcontrib><description>This chapter discusses the construction of multidrug resistance gene (MDR1) adeno-associated virus vectors (AAV) for gene therapy. Because of the large size of the MDR1 cDNA, the AAV coding sequences must be deleted prior to the insertion of MDR1 between the inverted terminal repeats (ITRs) of recombinant AAV (rAAV) vectors meant for transduction protocols. Whether all rep negative rAAV vectors are capable of stable integration, the mechanisms that contribute to site-specific integration needs to be investigated. The fact that rAAVs frequently remain episomal and may be diluted and lost with cell division may limit the use of AAV vectors when long-term expression is expected. Selectable markers, such as MDR1 may be possible to maintain nonintegrated episomal rAAV in proliferating cells because only cells carrying such episomal AAV-MDR1 survive the selection.</description><identifier>ISSN: 0076-6879</identifier><identifier>ISBN: 0121821935</identifier><identifier>ISBN: 9780121821937</identifier><identifier>EISSN: 1557-7988</identifier><identifier>DOI: 10.1016/S0076-6879(98)92042-0</identifier><identifier>PMID: 9711581</identifier><language>eng</language><publisher>United States: Elsevier Science & Technology</publisher><subject>Animals ; ATP Binding Cassette Transporter, Subfamily B, Member 1 - biosynthesis ; ATP Binding Cassette Transporter, Subfamily B, Member 1 - genetics ; Cell Line ; Cell Survival - drug effects ; Cytotoxins - toxicity ; Dependovirus - genetics ; Drug Resistance, Multiple - genetics ; Genetic Therapy - methods ; Genetic Vectors ; Humans</subject><ispartof>Methods in Enzymology, 1998, Vol.292, p.538-545</ispartof><rights>1998</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0076687998920420$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,779,780,784,793,3459,3550,4024,11288,27923,27924,27925,45810,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9711581$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Baudard, Marion</creatorcontrib><title>[40] Construction of MDR1 adeno-associated virus vectors for gene therapy</title><title>Methods in Enzymology</title><addtitle>Methods Enzymol</addtitle><description>This chapter discusses the construction of multidrug resistance gene (MDR1) adeno-associated virus vectors (AAV) for gene therapy. Because of the large size of the MDR1 cDNA, the AAV coding sequences must be deleted prior to the insertion of MDR1 between the inverted terminal repeats (ITRs) of recombinant AAV (rAAV) vectors meant for transduction protocols. Whether all rep negative rAAV vectors are capable of stable integration, the mechanisms that contribute to site-specific integration needs to be investigated. The fact that rAAVs frequently remain episomal and may be diluted and lost with cell division may limit the use of AAV vectors when long-term expression is expected. Selectable markers, such as MDR1 may be possible to maintain nonintegrated episomal rAAV in proliferating cells because only cells carrying such episomal AAV-MDR1 survive the selection.</description><subject>Animals</subject><subject>ATP Binding Cassette Transporter, Subfamily B, Member 1 - biosynthesis</subject><subject>ATP Binding Cassette Transporter, Subfamily B, Member 1 - genetics</subject><subject>Cell Line</subject><subject>Cell Survival - drug effects</subject><subject>Cytotoxins - toxicity</subject><subject>Dependovirus - genetics</subject><subject>Drug Resistance, Multiple - genetics</subject><subject>Genetic Therapy - methods</subject><subject>Genetic Vectors</subject><subject>Humans</subject><issn>0076-6879</issn><issn>1557-7988</issn><isbn>0121821935</isbn><isbn>9780121821937</isbn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kMlOwzAQhi0WlVL6CJV8hEPASxzbJ4TCVqkIieWEkOXEEzCicWWnlfr2pIuYyxz-0cw3H0ITSi4pocXVKyGyyAol9blWF5qRnGXkAA2pEDKTWqlDdEooo4pRzcURGv7Pn6BxSj-kr1yzXMoBGmhJqVB0iKYfOfnEZWhTF5d150OLQ4Ofbl8otg7akNmUQu1tBw6vfFwmvIK6CzHhJkT8BS3g7huiXazP0HFjfxOM932E3u_v3srHbPb8MC1vZhmwgnUZtT1gf50RwQTnjNYkb1ztgDZa93iqYU5IQXIAZnmuqkJzC4K7ijlXVJqP0GS3d7Gs5uDMIvq5jWuzf6nPr3c59BArD9Gk2kNbg_OxRzcueEOJ2Tg1W6dm48hoZbZODeF_9BJkgQ</recordid><startdate>1998</startdate><enddate>1998</enddate><creator>Baudard, Marion</creator><general>Elsevier Science & Technology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>1998</creationdate><title>[40] Construction of MDR1 adeno-associated virus vectors for gene therapy</title><author>Baudard, Marion</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e262t-1a821711205253321c04fdcde1f999248f2d57504ee2a348b693ae53db2dd6b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Animals</topic><topic>ATP Binding Cassette Transporter, Subfamily B, Member 1 - biosynthesis</topic><topic>ATP Binding Cassette Transporter, Subfamily B, Member 1 - genetics</topic><topic>Cell Line</topic><topic>Cell Survival - drug effects</topic><topic>Cytotoxins - toxicity</topic><topic>Dependovirus - genetics</topic><topic>Drug Resistance, Multiple - genetics</topic><topic>Genetic Therapy - methods</topic><topic>Genetic Vectors</topic><topic>Humans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Baudard, Marion</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Methods in Enzymology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baudard, Marion</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>[40] Construction of MDR1 adeno-associated virus vectors for gene therapy</atitle><jtitle>Methods in Enzymology</jtitle><addtitle>Methods Enzymol</addtitle><date>1998</date><risdate>1998</risdate><volume>292</volume><spage>538</spage><epage>545</epage><pages>538-545</pages><issn>0076-6879</issn><eissn>1557-7988</eissn><isbn>0121821935</isbn><isbn>9780121821937</isbn><abstract>This chapter discusses the construction of multidrug resistance gene (MDR1) adeno-associated virus vectors (AAV) for gene therapy. Because of the large size of the MDR1 cDNA, the AAV coding sequences must be deleted prior to the insertion of MDR1 between the inverted terminal repeats (ITRs) of recombinant AAV (rAAV) vectors meant for transduction protocols. Whether all rep negative rAAV vectors are capable of stable integration, the mechanisms that contribute to site-specific integration needs to be investigated. The fact that rAAVs frequently remain episomal and may be diluted and lost with cell division may limit the use of AAV vectors when long-term expression is expected. Selectable markers, such as MDR1 may be possible to maintain nonintegrated episomal rAAV in proliferating cells because only cells carrying such episomal AAV-MDR1 survive the selection.</abstract><cop>United States</cop><pub>Elsevier Science & Technology</pub><pmid>9711581</pmid><doi>10.1016/S0076-6879(98)92042-0</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0076-6879 |
| ispartof | Methods in Enzymology, 1998, Vol.292, p.538-545 |
| issn | 0076-6879 1557-7988 |
| language | eng |
| recordid | cdi_pubmed_primary_9711581 |
| source | MEDLINE; ScienceDirect eBooks; ScienceDirect Journals (5 years ago - present) |
| subjects | Animals ATP Binding Cassette Transporter, Subfamily B, Member 1 - biosynthesis ATP Binding Cassette Transporter, Subfamily B, Member 1 - genetics Cell Line Cell Survival - drug effects Cytotoxins - toxicity Dependovirus - genetics Drug Resistance, Multiple - genetics Genetic Therapy - methods Genetic Vectors Humans |
| title | [40] Construction of MDR1 adeno-associated virus vectors for gene therapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T16%3A36%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_elsev&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%5B40%5D%20Construction%20of%20MDR1%20adeno-associated%20virus%20vectors%20for%20gene%20therapy&rft.jtitle=Methods%20in%20Enzymology&rft.au=Baudard,%20Marion&rft.date=1998&rft.volume=292&rft.spage=538&rft.epage=545&rft.pages=538-545&rft.issn=0076-6879&rft.eissn=1557-7988&rft.isbn=0121821935&rft.isbn_list=9780121821937&rft_id=info:doi/10.1016/S0076-6879(98)92042-0&rft_dat=%3Cpubmed_elsev%3E9711581%3C/pubmed_elsev%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/9711581&rft_els_id=S0076687998920420&rfr_iscdi=true |